New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
09:26 EDTOREX
theflyonthewall.com: Orexigen trial data could increase obesity drug scrutiny, says Lazard Capital
Lazard Capital believes data from Orexigen's SCOUT trial could lead to increased regulatory scrutiny of obesity drugs. However, the firm maintains a Buy rating on the stock with a $12 price target. :theflyonthewall.com



News For OREX From The Last 14 Days
Check below for free stories on OREX the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 2, 2010
06:28 EDTOREX
theflyonthewall.com: Orexigen initiated with a Buy at Jefferies
Target $12. :theflyonthewall.com